ADME (Absorption, Distribution, Metabolism, and Excretion): Lead Characterization and Optimization
October 29, 2019
Introducing our newest CPRIT-funded GCC Center for Pharmacokinetics/Pharmacodynamics and Formulation (CCPF). Sponsored by CPRIT, CCPF, and the GCC Innovative Drug Discovery and Development Consortium, this conference will include a “How-to” session on approaching PK (ADME)/PD and formulation studies. Topics discussed will include protein:protein interactions, biologics, small molecules and examples of projects from users of the core. Additional sessions will include experts who will cover IND-enabling studies and regulatory considerations, and industry professionals who will present on current state-of-the-art and how those boundaries are being pushed as we move into the future of drug development.
Confirmed Speakers:
Leslie Benet
Professor
Bioengineering and Therapeutic Sciences
University of California San Francisco
S. W. Johnny Lau
Clinical Pharmacologist
Fadi Ibrahim
Senior Principal Scientist
Pfizer
Oscar Ekpenyong
Senior Scientist
Merck
Jeff Larson
VP
Product Development
Iterion
Stan Watowich
Professor
Biochemistry & Molecular Biology
UT Medical Branch at Galveston
Robert Tsai
Associate Professor
Center for Translational Cancer Research
Texas A&M Institute of Biosciences and Technology
Marc Cox
Professor
Biological Sciences
UT El Paso
Chun Li
Professor and Director
Cancer Systems Systems Imaging
MD Anderson Cancer Center
Cinzia Stella
Senior Scientist and Team Leader
Genentech
Diana Chow, University of Houston
Special thanks to CPRIT for their support of this Program.